TY  - JOUR
AU  - Margarit, Cesar
AU  - López, Rafael
AU  - Anton, Antonio
AU  - Escobar, Yolanda
AU  - Casas, Ana
AU  - Cruz, Juan Jesús
AU  - Galvez, Rafael
AU  - Mañas, Ana
AU  - Zaragozá, Francisco
PY  - 2012
DO  - 10.2147/JPR.S36428
UR  - http://hdl.handle.net/10668/1420
T2  - Journal of pain research
AB  - Breakthrough cancer pain is defined as transient pain exacerbation in patients with stable and controlled basal pain. Although variable, the prevalence of breakthrough cancer pain is high (33%-95%). According to the American Pain Foundation,...
LA  - en
PB  - Dove Medical Press
KW  - Prevalence
KW  - Management
KW  - Diagnosis
KW  - Opioids
KW  - Prevalencia
KW  - Diagnóstico
KW  - Analgésicos Opioides
KW  - Fentanilo
KW  - Pectinas
KW  - Dolor intercurrente
KW  - Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Pain::Breakthrough Pain
KW  - Medical Subject Headings::Health Care
KW  - Medical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Physiological Effects of Drugs::Peripheral Nervous System Agents::Sensory System Agents::Analgesics::Analgesics, Opioid
KW  - Medical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Piperidines::Fentanyl
KW  - Medical Subject Headings::Chemicals and Drugs::Macromolecular Substances::Polymers::Biopolymers::Pectins
KW  - Medical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Diagnosis
TI  - Breakthrough cancer pain - still a challenge.
TY  - research article
ER  -